The global Near infrared Imaging Market, valued at US$9.69 billion in 2023, stood at US$1.25 billion in 2025 and is projected to advance at a resilient CAGR of 10.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.07 billion by the end of the period. The key factors contributing to market growth include the increasing number of surgical procedures globally, advantages of near-infrared imaging over conventional visualization methods, technological advancements in near-infrared imaging modalities, and adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging. Furthermore, the growth potential for major players in emerging economies and the use of blockchain for the distribution and storage of medical images could underline the growth of the market in the coming years.
Additionally, emerging markets are expected to offer lucrative growth opportunities for market players during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174869738
By product, the device segment is expected to dominate the market during the forecast period. The device segment comprises fluorescence imaging systems and fluorescence & bioluminescence imaging systems. Key factors driving the growth of the device segment during this period include the advantages offered by this segment, including high-image resolution, high sensitivity, and real-time image guidance during surgeries.
By application, in 2024, the clinical imaging segment accounted for the largest market share. The Near IR imaging market is categorized into preclinical imaging, clinical imaging, and medical imaging. Key factors such as the advancements in fluorescence imaging for clinical applications and the increasing adoption of this imaging modality, owing to the advantages offered by this technique, are expected to drive the market growth of this segment in the coming years.
By geography, The Asia Pacific region is expected to register the highest CAGR of ~12% in the near IR imaging market. This region includes countries such as China, India, South Korea, Taiwan, and Singapore. The growth of the near IR imaging market is driven by the large patient population, the rising geriatric population, rapid economic growth, and increasing disposable income in the region.
As of 2024, the leading companies in the near IR imaging market include Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US), LI-COR Biotech (US), Hamamatsu Photonics K.K. (Japan), Quest Medical Imaging B.V. (Netherlands), and Merck KGaA (Germany).
Stryker (US):
Stryker has a strong background and expertise in the field of medical imaging. The company has extensive knowledge and experience in developing and manufacturing advanced imaging systems, which can be leveraged to produce near-infrared imaging devices. Stryker is also known for its commitment to technological innovation. The company invests in R&D to stay at the forefront of medical device advancements, develops cutting-edge technologies, and integrates them into its near-infrared imaging systems, ensuring the company is equipped with the latest features and capabilities. Stryker acquired MOLLI Surgical Inc. in July 2024, to add to its portfolio in near-infrared imaging. This acquisition combines the existing near-infrared imaging solutions of Stryker with surgical solutions of MOLLI Surgical in breast cancer care to strengthen its intraoperative imaging capabilities.
Leica Microsystems (US)
Leica Microsystems is one of the leading providers of advanced surgical visualization products. The company was the first to receive the FDA 510(k) clearance for a microscope for intra-operative angiography (FL800) and the first company offering a surgical microscope to integrate the three types of fluorescence capabilities (FL400, FL560, FL800) in a single product, TriFluoro. Leica constantly invests in R&D and partners with neurosurgeons to bring new, technologically advanced products. Additionally, Leica has sales and service organizations in 20 countries, with an international network of distribution partners in over 100 countries. Leica Microsystems released Mateo FL, an AI-powered digital fluorescence microscope, its advanced NIR fluorescence imaging platform, which integrates machine learning for improved tissue identification during surgery. It utilizes dual CMOS sensors to capture visible and fluorescent images simultaneously, enabling real-time mode switching and the overlay of pseudo-color ICG fluorescence on color or monochrome visuals.
Enquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=174869738